NCT01055769View on ClinicalTrials.gov

Bioequivalence Study Comparing Linezolid 600 Mg Oral Suspension With 600 Mg Tablet In Chinese Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Healthy Volunteers
Interventions
DRUG

Linezolid

"1. Linezolid OS 600 MG~2. Linezolid Tablet 600 MG"

DRUG

Linezolid

"1. Linezolid Tablet 600 MG~2. Linezolid OS 600 MG"

Trial Locations (1)

200040

Pfizer Investigational Site, Shanghai

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY